We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.74%
2 Financials 9%
3 Healthcare 8.22%
4 Consumer Discretionary 6.53%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
101
Unilever
UL
$136B
$199M 0.18%
3,268,694
+27,797
+0.9% +$1.77M
BSV icon
102
Vanguard Short-Term Bond ETF
BSV
$45.6B
$199M 0.18%
2,429,040
+752,695
+45% +$61.9M
BMY icon
103
Bristol-Myers Squibb
BMY
$132B
$198M 0.18%
3,344,233
+2,604
+0.1% +$171K
DVN icon
104
Devon Energy
DVN
$47.3B
$192M 0.17%
5,398,280
+4,866,983
+916% +$138M
USB icon
105
US Bancorp
USB
$99.6B
$188M 0.17%
3,170,398
+84,133
+3% +$4.79M
ADSK icon
106
Autodesk
ADSK
$52.6B
$186M 0.17%
653,650
+48,020
+8% +$14.7M
TSM icon
107
TSMC
TSM
$2.18T
$186M 0.17%
1,662,577
-80,258
-5% -$9.42M
INTC icon
108
Intel
INTC
$513B
$184M 0.17%
3,453,182
+29,586
+0.9% +$1.6M
GILD icon
109
Gilead Sciences
GILD
$165B
$180M 0.16%
2,575,633
-36,645
-1% -$2.57M
BX icon
110
Blackstone
BX
$110B
$180M 0.16%
1,544,876
-118,651
-7% -$13.8M
BND icon
111
Vanguard Total Bond Market
BND
$161B
$179M 0.16%
2,096,611
+121,956
+6% +$10.5M
NXPI icon
112
NXP Semiconductors
NXPI
$60.4B
$178M 0.16%
910,336
+25,090
+3% +$5.21M
AMGN icon
113
Amgen
AMGN
$222B
$178M 0.16%
837,952
-52,072
-6% -$12M
VGT icon
114
Vanguard Information Technology ETF
VGT
$149B
$177M 0.16%
3,523,848
+35,672
+1% +$1.85M
IWM icon
115
iShares Russell 2000 ETF
IWM
$81.9B
$176M 0.16%
806,786
-134,310
-14% -$29.8M
ROP icon
116
Roper Technologies
ROP
$39.8B
$176M 0.16%
393,809
+27,006
+7% +$12.9M
EQIX icon
117
Equinix
EQIX
$103B
$175M 0.16%
221,560
+45,582
+26% +$37.9M
IBM icon
118
IBM
IBM
$224B
$174M 0.16%
1,312,259
-50,445
-4% -$6.74M
GSLC icon
119
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16B
$174M 0.16%
2,017,041
+40,695
+2% +$3.61M
IVW icon
120
iShares S&P 500 Growth ETF
IVW
$77.6B
$173M 0.16%
2,344,511
-53,923
-2% -$4.11M
KMB icon
121
Kimberly-Clark
KMB
$36.5B
$173M 0.16%
1,306,690
+51,429
+4% +$6.99M
PM icon
122
Philip Morris
PM
$295B
$172M 0.15%
1,810,484
-29,654
-2% -$2.98M
MDY icon
123
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$171M 0.15%
355,950
-151,648
-30% -$74.5M
ZTS icon
124
Zoetis
ZTS
$30B
$169M 0.15%
870,504
-14,429
-2% -$2.91M
LIN icon
125
Linde
LIN
$226B
$168M 0.15%
567,043
+18,739
+3% +$5.7M

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.